Chronic pain – Talk Bio

Eli Lilly Acquires SiteOne for Up to $1B to Expand Non-Opioid Pain Pipeline

2 weeks ago talkbio0Tagged Acquisition, Chronic pain, Drug Industry, eli lilly, Nav1.8 inhibitor, neuroscience pipeline, non-opioid pain treatment, SiteOne Therapeutics, STC-004

Eli Lilly; SiteOne Therapeutics; non-opioid pain treatment; STC-004; acquisition; Nav1.8 inhibitor; chronic pain; neuroscience pipeline; Vertex; pharmaceutical industry

Latigo saddles up with $150M to spur non-opioid pain drugs through the clinic

3 months ago talkbio0Tagged Acute onset pain, biotherapeutics, Chronic pain, Clinical Trials, inhibitors, Latigo, non-opioid pain drugs, SCN10A gene, Series B

Latigo Biotherapeutics, non-opioid pain drugs, Nav1.8 inhibitors, Series B funding, clinical trials, acute pain, chronic pain

Abbott’s Spinal Cord Stimulation Systems Demonstrate Long-Term Efficacy in Chronic Pain Management

4 months ago talkbio0Tagged abbott, Approved, BurstDR, Chronic pain, Neurostimulation procedures of spinal cord tissue, non-surgical back pain, Stimulation procedure, Svalbard, United States Food and Drug Administration, XR

Abbott, spinal cord stimulation, chronic pain, BurstDR stimulation, Proclaim Plus, Proclaim XR, FDA approval, non-surgical back pain